Align Technology Boosted By Improving Sentiment, Easing Comps, Margins, Earns Analyst Upgrade
Align Technology Boosted By Improving Sentiment, Easing Comps, Margins, Earns Analyst Upgrade
Leerink Partners upgraded Align Technology Inc (NASDAQ:ALGN), citing upside opportunities throughout 2025 given gross margin expansion opportunities.
Leerink Partners將艾利科技公司（納斯達克：ALGN）評級上調，指出在2025年期間，由於毛利率擴張機會存在上行潛力。
Align Technology — a medical device company that manufactures and sells dental aligners, scanners, and software for digital orthodontics and restorative dentistry — will benefit from improving consumer sentiment, easing comps and continued equipment traction with Lumina.
艾利科技是一家制造和銷售牙齒矯正器、掃描儀和數字正畸及修復牙科軟體的器械公司，將受益於消費者情緒改善、比較基數降低以及與Lumina的持續設備吸引力。
In October, Align Technology announced that it is planning to repurchase $275 million of its common stock through open market repurchases under its $1 billion stock repurchase program, which was approved by Align's Board of Directors in January 2023.
在十月，艾利科技宣佈將通過其10億美元的股票回購計劃在開放市場回購27500萬美元的普通股，該計劃於2023年1月獲得艾利董事會批准。
Also Read: What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
另請閱讀：牙科企業帕特森的41億交易對其他參與者意味着什麼？
Analyst Michael Cherny still does not anticipate an entirely risk-free situation. Average selling price (ASP) pressures could lead to short-term fluctuations, and unpredictable consumer data may cause stock volatility.
分析師Michael Cherny仍然不預期完全無風險的情況。平均銷售價格（ASP）壓力可能導致短期波動，而不可預測的消費者數據可能導致股票波動。
However, the analyst writes the positives outweigh the negatives.
然而，分析師表示積極因素超過了消極因素。
Align has consistently outperformed competitors through innovation, competitive advantages, and relationships with dentists.
艾利通過創新、競爭優勢和與牙醫的關係始終優於競爭對手。
Cherny adds that the previous market perform rating reflected expectations of a weaker fiscal year in 2024 due to challenging economic conditions and uncertainty about the earnings impact of new product launches.
Cherny補充說，之前的市場表現評級反映了對2024財年由於經濟條件艱難和新產品發佈對收益影響的不確定性而降低的預期。
Leerink sees a clearer path for growth in fiscal 2025. Operational efficiencies will likely drive additional profit gains beyond that year.
Leerink認爲2025財年增長的前景更加清晰。運營效率可能會在這一年之後推動額外的利潤增長。
Leerink has upgraded Align Technology from Market Perform to Outperform, with a price target of $280 from $235.
Leerink將艾利科技的評級從市場表現上調至跑贏大盤，目標價格從235美元提升至280美元。
In the third quarter, Align Tech reported adjusted EPS of $2.35, better than the consensus of $2.31, while sales increased 1.8% to $977.9 million, below the consensus of $987.34 million.
在第三季度，艾利科技報告的每股收益調整爲2.35美元，優於2.31美元的共識預期，同時銷售額增長1.8%，達到97790萬低於98734萬的共識預期。
Most recently, Align Technology received a CE Mark in Europe for Align's Invisalign Palatal Expander System.
最近，艾利科技在歐洲獲得了Align的Invisalign齶擴張器系統的CE認證。
The Invisalign Palatal Expander System has also completed registration with MHRA for the United Kingdom and overseas territories.
Invisalign齶擴張器系統也已在英國和境外地區完成MHRA註冊。
Price Action: Align stock is up 6.45% at $221.68 at last check Monday.
價格動態：艾利科技股票在週一最後一次檢查時上漲6.45%，報221.68美元。
- XPeng Teams Up With Real-Time Innovations For Smarter EVs: Details
- 小鵬與實時創新合作，打造更智能的電動車：詳情
Image: Shutterstock
圖片：Shutterstock
譯文內容由第三人軟體翻譯。
